COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations

The ongoing and seemingly endless COVID-19 (SARS-CoV-2) pandemic is not only a global health crisis, but it has also highlighted a number of pre-existing problems, including access to health care, greater severity of COVID-related complications for those with poor lifestyle behaviors of cardiometabolic diseases, and the added complexities underserved populations face with seeking and gaining access to essential healthcare services. Below we pose some of the many questions of interest to chronic disease management (summarized in Fig. 1), with an emphasis on cardiometabolic disease, during and following COVID-19. On behalf of HL-PIVOT (Healthy Living for Pandemic Event Protection) and Exercise is Medicine® (EIM) Underserved & Community Health, this special issue aims to expand the discourse related to the short- and long-term impact of COVID-19 on individual and public health. Below we pose some of the many topics of interest to chronic disease management, with an emphasis on cardiometabolic disease. during and following COVID-19. The intention of this section is to ignite interest in this special issue and spur continued discourse from authors across the biomedical spectrum.